Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.» Read More
Is it time for investors to feast on food stocks? David Palmer thinks that's a reasonable assumption. "They're a decent place to be," the UBS senior restaurant analyst told CNBC. "Input costs are coming off their highs; certainly, people have to eat, so, as people look for cheaper calories, (packaged food companies) should be doing OK."
These days the most cash-rich companies often sell mobile phones rather than mortgages. Cramer tells you who's who in the changing market landscape.
Stocks ended higher Tuesday, snapping a three-day losing streak, after strong earnings from Merck and a better-than-expected housing report lifted sentiment on the Street.
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!
Investors can’t help but wonder what’s the best way to play Pharma after Pfizer said it would buy rival Wyeth for $60 billion, a 20% premium!
A recession-resistant play with a nice dividend yield in a period of declining commodity prices? Maybe.
Happy Birthday By The Numbers! Today is the first anniversary of the launch of By The Numbers. We debuted in January 2008 as a top ten CNBC.com blog, and shortly after, were awarded an internal recognition as the "Fastest Growing Blog."
The pressure's on Obama to save the economy. His presidency will succeed, or fail, with the markets.
I was always waiting for a high-powered Wheaties and rumors are circulating that General Mills is in the planning stages of making that happen. The idea we’re told, is a male-targeted product that would give the brand some more credibility.
Retailer Best Buy said it sees sales at stores open at least one year falling between 2 percent and 3 percent for its current fiscal year and said its market share continued to gain, while General Mills raised guidance.
Investors in GIS aren’t looking for the explosive growth of a tech stock, they want consistency. And that’s just what they get from a company that hasn’t missed a quarterly payment in 110 years.
Will M&A activity boost biotech stocks in 2009?
Biotechnology stocks are getting a lot of chatter already in this very young year.
RidgeWorth Capital Management's Alan Gayle thinks it's time to move up the risk gauge — in both stocks and bonds.
Following are the year’s biggest winners and losers. Find out why shares of McDonald’s and Gilead Sciences popped while General Motors and Citigroup dropped.
Merck, Lilly and Pfizer are all trading substantially higher. Will this bear market remedy keep working in the new year?
Here’s our Fast Money Final Trade. Our gang gives you Monday’s best trades, right now.
Looking for some holiday cheer, this Christmas Eve.? Here are some stocks that have won big this past year.
Cramer makes the call on viewers' favorite stocks.
General Mills and Joy Global offer different paths to profit. It’s up to you to decide which one is the right investment.